The Global Iboga Authority

The Scientific Frontier of Advanced Brain Health & Neurological Recovery

Bridging the gap between ancient plant medicine and modern neuroscience. IbogaHealth.org is the premier global directory and research hub connecting patients, clinicians, and researchers with ethical, medically-backed Iboga-derived therapies for Parkinson’s, TBI, and cellular neuro-regeneration.

40+

Verified Global Centers

100%

Medical Staff Audited

Peer

Reviewed Research Base

Amber dropper / TA extract

Iboga bark

Tabernanthe iboga

Parkinson’s Research

TBI Neuro-Regeneration

GDNF Expression

Certified Clinical Centers

Lab-Verified Purity

Ethical Sourcing

Tabernanthe iboga

Apocynaceae · West-Central Africa

Mission & Vision

Setting Ethical and Medical Standards for Global Iboga Therapy

At IbogaHealth.org, our mission is to elevate the therapeutic use of Tabernanthe iboga through a strict neuroscientific lens. We act as an independent, rigorous bridge — vetting leading international centers, medical professionals, and laboratory-verified products to ensure patients have safe, ethical access to groundbreaking neurological interventions.

Our Vision: to serve as the definitive global point of reference for responsible ibogaine use — championing clinical innovation, peer-reviewed patient education, and global transparency.

Product Transparency

Medical Standards

Clinical Focus

Targeting Neurodegenerative & Structural Brain Conditions.

While widely recognized for interrupting chemical dependencies, modern research shows iboga alkaloids possess unprecedented properties for structural brain repair, neuroprotection, and proactive cognitive optimization.

The Mechanism

Iboga Alkaloids (Ibogaine / Noribogaine)

↓ Triggers GDNF & Neuroplasticity

Neurodegenerative

Parkinson's

Dopaminergic Protection

Upregulated GDNF fosters the survival, growth, and differentiation of dopaminergic neurons — a novel vector for managing symptoms.

Structural

TBI Recovery

Neural Pathway Reconstruction

Protocols stimulate rapid neuroplasticity, helping the brain bypass damaged networks and repair axonal pathways.

Wellness

Microdosing

Brain Health Optimization

Sub-perceptual dosing as a proactive tool for neurological wellness, guided by evidence-based scheduling frameworks.

Safety

Screening Hub

Screening & Vetting

Non-negotiable pre-screening — 12-lead EKG / QTc, liver panels, and cardiac & psychiatric contraindication review.

Neural network visualization

Ibogaine for Parkinson's Disease & Dopaminergic Health

Research indicates ibogaine upregulates GDNF (Glial Cell Line-Derived Neurotrophic Factor). This protein fosters the survival, growth, and morphological differentiation of dopaminergic neurons — offering a novel therapeutic vector for managing Parkinson’s symptoms and slowing progressive neurodegeneration.

Traumatic Brain Injury (TBI) & Neuro-Regeneration Therapy

Blast injuries, sports concussions, and long-term cognitive wear create chronic, low-grade neuroinflammation. Iboga-derived protocols stimulate rapid neuroplasticity — helping the brain bypass damaged neural networks, reduce systemic inflammation, and repair damaged axonal pathways.

Clinicians reviewing neuro-imaging

Iboga extract — TA / HCl

Iboga-Derived Products & Microdosing Guidance

Beyond specific pathologies, sub-perceptual microdosing serves as a tool for proactive neurological wellness. Explore the scientific differences between Total Alkaloid (TA) extracts, purified ibogaine HCl, and raw bark — and learn evidence-based scheduling frameworks like the Fadiman protocol.

Patient Screening, Safety & Contraindications Hub

Solidifying our position as the global authority on responsible iboga administration, our dedicated safety hub covers non-negotiable health checks — mandatory resting 12-lead EKGs to track QTc intervals, liver-panel metrics, and dangerous psychiatric or cardiac medication contraindications.

Patient screening consultation

The Hub

Evidence-Led Innovation: Research, Data, and Global Advocacy.

Long-term access to alternative medicines requires undeniable clinical proof. Discover how we are documenting the revolution.

Research

The Latest Ibogaine Research Hub

Access our verified directory of double-blind studies, ongoing clinical trials, and pharmacology papers. We track how ibogaine and its active metabolite, noribogaine, cross the blood-brain barrier to restructure neuro-pathways.

Read peer-reviewed literature on Ibogaine & GDNF →

In the News

Iboga In the News & Media Center

Stay current with real-time global policy shifts, breakthroughs in mainstream psychiatric research, and investigative journalism covering the regulatory paths of psychedelic therapies worldwide.

Explore press releases & legislative updates →

Credibility

Your Trusted Authority Marketplace.

Whether you are a patient, a referring provider, or an authorized research entity, our multi-tiered validation model ensures absolute quality control.

Clinical consultation

Verified Directory Perks

Lab-verified product

Ethical Product Standards

Advisory / integration

Patient Advocacy Tools

From Seed to Science

Documenting the global network.

Iboga cultivation

Extraction droplet

Hand-harvested bark

Amber vials row

Laboratory testing

Clinician network

Frequently Asked

Questions answered.

What conditions does iboga-derived therapy target?

Beyond its known role in interrupting chemical dependency, current research focuses on neurodegenerative and structural brain conditions — Parkinson’s (dopaminergic protection via GDNF), traumatic brain injury and neuro-regeneration, and proactive cognitive optimization through microdosing.

How do we vet clinical centers?

Every listed center passes a multi-tiered validation model: 100% medical-staff auditing, verification of on-site ACLS cardiac equipment, and confirmation of certified neuro-specialists. Only centers meeting our standards appear in the directory.

What is the difference between Ibogaine HCl, TA extract, and raw bark?

Purified ibogaine HCl is a single isolated alkaloid; Total Alkaloid (TA) extract retains the plant’s full alkaloid profile; raw bark is unprocessed Tabernanthe iboga. They differ in potency, predictability, and appropriate use — from clinical protocols to sub-perceptual microdosing.

What pre-screening is required before treatment?

Responsible administration requires non-negotiable health checks, including a resting 12-lead EKG to assess QTc intervals, liver-function panels, and a full review of psychiatric and cardiac medication contraindications.

How does Iboga support Parkinson's and TBI recovery?

Early-stage research indicates iboga alkaloids upregulate GDNF, a protein linked to the survival and growth of dopaminergic neurons, and may stimulate neuroplasticity that helps the brain route around damaged pathways. These findings are emerging and not a substitute for a physician’s evaluation.

Are you a clinic?

No. IbogaHealth.org is an independent global directory and research hub. We do not provide treatment — we connect patients, clinicians, and researchers with vetted centers, products, and peer-reviewed information.

Connect

Connect with Verified Neuro-Restorative Professionals.

Don’t navigate alternative brain health therapies alone. Trust the verified data, peer-reviewed medical standards, and honest user reviews curated by the world’s leading Iboga network.

The global directory and research hub for ethical, neuroscientific Iboga-derived therapies — connecting patients, clinicians, and researchers worldwide.